Calyxt Inc (NASDAQ:CLXT) Receives Average Recommendation of “Hold” from Analysts

Calyxt Inc (NASDAQ:CLXT) has been assigned an average rating of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $19.25.

CLXT has been the topic of several research analyst reports. BMO Capital Markets lowered their price objective on shares of Calyxt to $15.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Zacks Investment Research downgraded shares of Calyxt from a “hold” rating to a “sell” rating in a research note on Monday, December 2nd. Finally, BidaskClub upgraded shares of Calyxt from a “strong sell” rating to a “sell” rating in a research note on Thursday, September 12th.

CLXT stock traded up $0.49 during midday trading on Friday, hitting $6.05. 100,445 shares of the company traded hands, compared to its average volume of 87,126. Calyxt has a twelve month low of $3.55 and a twelve month high of $19.30. The company has a quick ratio of 11.97, a current ratio of 12.38 and a debt-to-equity ratio of 0.25. The business has a 50 day simple moving average of $4.44 and a 200-day simple moving average of $7.79. The stock has a market capitalization of $199.35 million, a price-to-earnings ratio of -6.65 and a beta of 2.27.

Calyxt (NASDAQ:CLXT) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by ($0.01). The company had revenue of $2.97 million during the quarter. Calyxt had a negative return on equity of 43.09% and a negative net margin of 1,016.27%. Equities research analysts forecast that Calyxt will post -1.18 EPS for the current year.

Several institutional investors have recently made changes to their positions in the company. BlackRock Inc. grew its stake in shares of Calyxt by 33.2% in the second quarter. BlackRock Inc. now owns 619,801 shares of the company’s stock worth $7,735,000 after acquiring an additional 154,598 shares during the last quarter. Nikko Asset Management Americas Inc. lifted its position in Calyxt by 8.6% in the third quarter. Nikko Asset Management Americas Inc. now owns 573,323 shares of the company’s stock worth $3,234,000 after purchasing an additional 45,541 shares during the period. Sumitomo Mitsui Trust Holdings Inc. lifted its position in Calyxt by 8.6% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 573,323 shares of the company’s stock worth $3,234,000 after purchasing an additional 45,541 shares during the period. Vanguard Group Inc. lifted its position in Calyxt by 6.2% in the second quarter. Vanguard Group Inc. now owns 418,073 shares of the company’s stock worth $5,218,000 after purchasing an additional 24,559 shares during the period. Finally, State Street Corp lifted its position in Calyxt by 7.7% in the third quarter. State Street Corp now owns 136,955 shares of the company’s stock worth $772,000 after purchasing an additional 9,775 shares during the period. Institutional investors and hedge funds own 27.21% of the company’s stock.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.

See Also: What is systematic risk?

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.